Work

Frailty and Adherence to Adjuvant Hormonal Therapy in Older Women With Breast Cancer: CALGB Protocol 369901

Year: 2020

Type: article

Abstract: Most patients with breast cancer age ≥ 65 years (ie, older patients) are eligible for adjuvant hormonal therapy, but use is not universal. We examined the influence of frailty on hormonal therapy noninitiation and discontinuation.

Source: Carolina Digital Repository (University of North Carolina at Chapel Hill)

DOI: 10.17615/5sdb-jh20

Authors: Hurria, Arti, Isaacs, Claudine, Kimmick, Gretchen, Sheppard, Vanessa B., Tallarico, Michelle, Winer, Eric P., Pitcher, Brandelyn N., Faul, Leigh Anne, Wang, Judy Huei-yu, Hudis, Clifford, Mandelblatt, Jeanne S., Barry, William T., Yung, Rachel L., Cohen, Harvey J., Muss, Hyman B., Luta, George, Clapp, Jonathan D.

Language: English

Topic: Frailty in Older Adults

Subfield: Geriatrics and Gerontology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Amgen, National Institutes of Health, National Cancer Institute

Awards: G1339790776, G1789622963, G2456654821, G2647518335, G2908610394, G3608028149, G7164258251, Cancer Control at the Intersection of Aging Research, G8929477131, G9000019050, G9000052491, G9000096334, G9000130730, G9000152819, G9000302272, Georgetown University Lombardi Comprehensive Cancer Center Support Grant, G973482110

OpenAlex ID: W4299514960

FWCI:

Cites:

Cited by:

Related to: 10